Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 1800270073-A No ClinicalTrials.gov identifier reported
- 1800270073-B No ClinicalTrials.gov identifier reported
- 1800270073-C No ClinicalTrials.gov identifier reported
- 18-004256 A Randomized Double-Blinded Placebo-Controlled Trial Compaing a Multi-Modal Pain Protocol With and without Schedule II Narcotics Following Total Joint Arthroplasty No ClinicalTrials.gov identifier reported
- 18-005i No ClinicalTrials.gov identifier reported
- 18-089 A Phase I/II Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma or Patients With Richter's Syndrome No ClinicalTrials.gov identifier reported
- 18-2587 Understanding Symptoms and Impacts Associated with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Evaluating the Pulmonary Arterial Hypertension. Symptoms and Impact (PAH SYMPACT) Measure among Patients with CTEPH No ClinicalTrials.gov identifier reported
- 18281 No ClinicalTrials.gov identifier reported
- 18281_R No ClinicalTrials.gov identifier reported
- 18-282 No ClinicalTrials.gov identifier reported
- 1833-201-407 Ph2 Clinical Study (M21-467) NCT04499248
- 18-432 NCT03703167
- 18-432 No ClinicalTrials.gov identifier reported
- 1-84 PTH XS (Project 500692) No ClinicalTrials.gov identifier reported
- 18-613 No ClinicalTrials.gov identifier reported
- 18-Avp-786-107 No ClinicalTrials.gov identifier reported
- 18-Avp-786-108 No ClinicalTrials.gov identifier reported
- 18-Avp-786-207 No ClinicalTrials.gov identifier reported
- 18-Br-0001 No ClinicalTrials.gov identifier reported
- 18F-anti-PD-L1 PET in EG cancer No ClinicalTrials.gov identifier reported
- 18F-Av-1451 PET Imaging in Subjects With Frontotemporal Dementia NCT03040713
- 18F-DCFPyL PET/CT in Men with Prostate Cancer No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET/CT in the Evaluation of Patients with BCR of Prostate Cancer and Non-Contributory CT Scans No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET/CT in the Evaluation of Patients with BCR of Prostate Cancer and Non-Contributory CT Scans No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET in Men with Prostate cancer, single-arm prospective trial. Phase 2 Study of18F-DCFPYL Positron Emission Tomography (PET) in Men with Newly Diagnosed Progressive or Metastatic Prostate Cancer No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET in Men with Prostate cancer, single-arm prospective trial. Phase 2 Study of18F-DCFPYL Positron Emission Tomography (PET) in Men with Newly Diagnosed Progressive or Metastatic Prostate Cancer No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET in Men with Prostate cancer, single-arm prospective trial. Phase 2 Study of18F-DCFPYL Positron Emission Tomography (PET) in Men with Newly Diagnosed Progressive or Metastatic Prostate Cancer No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET in Men with Prostate cancer, single-arm prospective trial. Phase 2 Study of18F-DCFPYL Positron Emission Tomography (PET) in Men with Newly Diagnosed Progressive or Metastatic Prostate Cancer No ClinicalTrials.gov identifier reported
- 18F-DCFPyL PET in Men with Prostate cancer, single-arm prospective trial. Phase 2 Study of18F-DCFPYL Positron Emission Tomography (PET) in Men with Newly Diagnosed Progressive or Metastatic Prostate Cancer No ClinicalTrials.gov identifier reported
- 18FFACBCand 18F FLT PET Imaging in Central Nervous System Tumors NCT00832598
- 18F-FLUC-CEST PET/MR in Patients With Brain Mets NCT06159335
- 18F-FLUC-CEST PET/MR in Patients With Brain Mets NCT06159335
- 18F-Fluciclovine and 68Ga-PSMA-11 PET/CT forDetection of Invasive Lobular Breast Cancer:Interim Report from an Exploratory Trial No ClinicalTrials.gov identifier reported
- 18FFluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone RROPE Study NCT03707184
- 18FFluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone RROPE Study NCT03707184
- 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery (FACILITATE) NCT06048094
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer NCT06706921
- 18F-Fluciclovine PET/CT in Multiple Myeloma NCT06103838
- 18F-Fluciclovine PET Discrimination of Radiation Injury to the Brain NCT04462419
- 18F-Fluciclovine PET Discrimination of Radiation Injury to the Brain NCT04462419
- 18F-Fluciclovine PET Discrimination of Radiation Injury to the Brain NCT04462419
- 18F-Fluciclovine PET Discrimination of Radiation Injury to the Brain NCT04462419
- 18F-Fluciclovine PET Discrimination of Radiation Injury to the Brain NCT04462419
- 18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy (DRARCH) NCT05479136
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Abiraterone Acetate NCT04158245
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Abiraterone Acetate NCT04158245
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Abiraterone Acetate NCT04158245
- 18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain NCT04462419
- 18F-Fluciclovine PET-MRI in High-grade Glioma NCT05553041
- 18F-Fluoroestradiol (FES) Positron Emission Tomography for the Detection and Treatment Response Monitoring in Patients with Metastatic Lobular Breast Carcinoma No ClinicalTrials.gov identifier reported